Top 10 Medtech VCs - 2024

Trish founded Portfolia with a vision to activate the capital of women to invest in the companies we want in the world. Portfolia now has 13 funds and has made 92 investments in 66 top innovative companies.

Trey Bowles is currently the Managing Director of Techstars where he runs two accelerator programs: Techstars Anywhere and Techstars Physical Health Fort Worth. Trey is also the CoFounder and President of InnoCity Partners LLC, a boutique consulting firm focused on supporting cities/municipalities, corporations, and innovators working to develop innovative solutions for their communities that support and create the best place for their citizens to live, work, and play

Joe Vacca is a Managing Partner at Ringbolt Capital, a venture capital firm located near Washington, D.C. As a leading marketing and strategy executive, Joe has played a key role in accelerating growth across multiple sectors. Joe was involved at the start of a number of new industries including the private student loan industry, the personal information security industry

Paul Grand is CEO of MedTech Innovator, the largest life science accelerator in the world and the premier global accelerator for the medical technology industry. Grand has an extensive global network in transformative medical innovation.

Jan has led and held board roles in more than 25 investments across six funds including notable exits with HandyLab (acquired by BD), Esperion (Nasdaq: ESPR), NxThera (acquired by Boston Scientific), CardioMEMS

Alex Morgan is currently a Partner at Khosla Ventures, a Silicon Valley VC firm which invests broadly in technology from seed stage funding to later stage capital investments. Alex has a special focus on biotechnology, healthcare, and data science. Alex has worked extensively in machine learning, natural language processing, genomics, and healthcare.

Christopher Herr is the Senior Managing Director, Oxford Finance LLC. Oxford Finance delivers flexible financial solutions to companies worldwide across multiple sectors, including life sciences, healthcare, business services and software & technology.

David is a Partner at Qiming Venture Partners, focusing on fundraising and investor relations for Qiming’s USD funds. David has over 20 years of experience in the U.S. and China’s venture capital ecosystems as a limited partner, financial advisor to entrepreneurs, and venture capitalist.

Kirk Nielsen is a Managing Partner at Vensana Capital, a medtech-focused venture capital and growth equity firm launched with the support of Versant Ventures. He joined Versant Ventures in 2006, where he led or co-led investments in numerous successful companies. Before his venture capital career, Kirk worked at Medtronic in sales and marketing and served as a consultant at Bain & Company.

Igor DaCruz is a Managing Director and Head of Credit and Portfolio at Trinity Capital's Life Sciences group. With over 13 years of experience in the finance sector, he has advised numerous innovative companies in the technology and life sciences industries. Before joining Trinity Capital, Igor held significant roles at Runway Growth Capital, Union Bank, and Silicon Valley Bank.